- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06552949
A Prospective Cohort of Emergent Laparoscopic Cholecystectomy in PUMCH (ELC-PUMCH)
Prospective Cohort Study on Emergent Laparoscopic Cholecystectomy Guided by Indocyanine Green (ICG) Fluorescence Versus Conventional Laparoscopic Operation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Acute calculous cholecystitis, typically occurs in patients with gallstones, accounts for 90 to 95% of acute cholecystitis. Emergent laparoscopic cholecystectomy (ELC) is the major treatment option. Traditionally, the time frame for ELC is generally considered to be within 72 hours from the onset of symptoms. However, with the development of surgical techniques, nowadays, ELC is also considered for patients with symptoms onset within 10 days and hospital stays within 7 days. The determination of the time frame for ELC in acute cholecystitis is primarily based on the risk of complications occurring. Comparing to delayed laparoscopic cholecystectomy (DLC), ELC has advantages in post-operative complications in patients with symptoms onset within 72 hours. Post-operative complications for both DLC and ELC include bile leaks, intestinal obstruction, ascites, intraperitoneal hemorrhage, would bleeding and hematoma, wound infection and calculus remaining. Most of them associate with intraoperative procedures. Emergent laparoscopic cholecystectomy guided by indocyanine green (ICG) cholangiography (ELC-ICGC), comparing to conventional LC, potentially can help the surgeons to identify bile tracts and therefore may reduce the complications.
From August 1st 2020, the AC patients undergoing LC in PUMCH were prospecteively registered and a database was established to collect related data.
Till 1st Feburary 2024, about 750 cases of ELC were performed. The surgeons chose to perform either conventional ELC or ELC-ICGC based on their discretion. The patients were followed up within one month after discharge in out patient clinic or telephone interview. We plan to analyze the data from the prospectively established- database.
The surgical outcomes are evaluated by both intraoperative events and postoperative events. Intraoperative events contain the following items: (1) incidence of intraoperative accidental bile tract injury, (2) intraoperative bleeding (volume), (3) operation time. Postoperative events contain the following items: (1) incidence of complications staging 2 and above according to Clavien Dindo Grade during hospital stay, (2) duration of postoperative hospital stay. The economic effectiveness is evaluated by cost of hospital stay.
The surgical outcomes of these two procedures will be compared.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100730
- Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients underwent ELC performed by the emergent surgeon team Approval to participate
Exclusion Criteria:
- Patients with incomplete medical records. Patients have other emergent conditions which warrant other emergent operations or major treatment simultaneously besides ELC.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study group
Patient undergoing emergent laparoscpic cholecystectomy guided by indocyanine green cholangiography (ELC-ICGC)
|
Emergent conventional laparoscopic cholecystectomy
|
|
Control group
Patient undergoing emergent conventional laparoscopic cholecystectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of intraoperative accidental bile tract injury
Time Frame: within 1 month
|
The primary outcome is incidence of intraoperative accidental injury involving the bile tract in emergent laparscopic cholecystectomy (ELC) guided by ICG fluorescence.
The injury manifests as biliary obstruction, biliary leak, or biliary stricture.
Medical records will be reviewed to identify an intraoperative bile tract injury event.
Incidence of intraoperative accidental bile tract injury will be collected and comparison between study group (ELC guided by ICG fluorescence) and control group (conventional ELC) will be made
|
within 1 month
|
|
incidence of complications
Time Frame: within 1 month
|
incidence of complications staging 2 and above according to Clavien Dindo Grade during hospital stay
|
within 1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
intraoperative bleeding (volume)
Time Frame: Intraoperative
|
Volume of intraoperative bleeding during the operation
|
Intraoperative
|
|
duration of postoperative hospital stay
Time Frame: within 1 month
|
Days of postoperative hospital stay
|
within 1 month
|
|
total medical expense
Time Frame: within 1 month
|
Cost during hospital stay
|
within 1 month
|
|
operation time
Time Frame: Intraoperative
|
from cutting the incison to ending the suturing of the incision
|
Intraoperative
|
Collaborators and Investigators
Investigators
- Study Chair: Qiaofei Liu, M.D, Department of General Surgery, Peking Union Medical College Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- K6454-K24C2458
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Cholecystitis
-
Hospital General de Chihuahua - Dr. Salvador Zubirán...CompletedAcute Cholecystitis | Acute Cholecystitis With ObstructionMexico
-
Konya Meram State HospitalCompleted
-
Azienda Ospedaliero, Universitaria PisanaCompletedAcute CholecystitisItaly
-
University Hospital, GhentCompletedUncomplicated Acute CholecystitisBelgium, Qatar
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingAcute Calculous Cholecystitis Candidate to Early CholecystectomyItaly
-
IRCCS Policlinico S. MatteoCompleted
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingHigh-risk Patients With Acute Calculous Cholecystitis (ACC)Italy
-
Aichi Medical UniversityRecruitingAcute Calculous CholecystitisJapan
-
The University of Texas Health Science Center at...CompletedAcute Cholecystitis | Chronic CholecystitisUnited States
-
Istituto Clinico Humanitas Mater DominiRecruiting
Clinical Trials on Emergent laparoscopic cholecystectomy guided by ICG cholangiography (ELC-ICGC)
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruiting
-
Peking Union Medical College HospitalCompletedAcute Cholestatic HepatitisChina
-
West China HospitalRecruiting
-
Aristotle University Of ThessalonikiGeorge Papanicolaou HospitalRecruitingIntraoperative Complications | Choledocholithiasis | Post-Op Complication | Indocyanine Green | Bile Duct Injury | Stone - Biliary | Laparoscopic; Cholecystectomy | Cholelithiasis; Bile Duct | CholangiographyGreece